Clinical Trial

Maternal Hyperoxygenation in Congenital Heart Disease

Study Description

Maternal Hyperoxygenation in Congenital Heart Disease

A pilot study investigating the safety and feasibility of chronic maternal hyperoxygenation in the setting of fetal congenital heart disease

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Maternal Hyperoxygenation

Oxygen via nasal prongs at 4L/min continuously during 2nd and 3rd trimester of pregnancy until birth

Additional Information

Official Study Title

Maternal Hyperoxygenation in Congenital Heart Disease

Clinical Trial ID

NCT03136835

ParticipAid ID

QdJk2e